Option Care Health, Inc. (NASDAQ:OPCH) Shares Purchased by Jennison Associates LLC

Jennison Associates LLC lifted its position in Option Care Health, Inc. (NASDAQ:OPCH) by 26.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 472,274 shares of the company’s stock after purchasing an additional 99,139 shares during the quarter. Jennison Associates LLC owned about 0.28% of Option Care Health worth $14,782,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Avior Wealth Management LLC increased its holdings in shares of Option Care Health by 11.2% during the 3rd quarter. Avior Wealth Management LLC now owns 24,300 shares of the company’s stock worth $761,000 after buying an additional 2,442 shares during the last quarter. Pathstone Holdings LLC grew its position in Option Care Health by 9.8% in the third quarter. Pathstone Holdings LLC now owns 68,895 shares of the company’s stock worth $2,156,000 after acquiring an additional 6,134 shares during the period. Lindenwold Advisors INC raised its position in Option Care Health by 5.4% in the third quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock valued at $299,000 after purchasing an additional 489 shares during the period. Thrivent Financial for Lutherans lifted its stake in shares of Option Care Health by 7.4% in the 3rd quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company’s stock valued at $183,541,000 after purchasing an additional 404,811 shares during the last quarter. Finally, Natixis Advisors LLC lifted its stake in shares of Option Care Health by 9.3% in the 3rd quarter. Natixis Advisors LLC now owns 88,751 shares of the company’s stock valued at $2,778,000 after purchasing an additional 7,529 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of Option Care Health stock in a transaction that occurred on Friday, November 8th. The shares were purchased at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the acquisition, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.64% of the stock is currently owned by company insiders.

Option Care Health Stock Performance

Shares of OPCH stock opened at $23.13 on Friday. The firm has a 50 day moving average of $27.62 and a two-hundred day moving average of $29.11. The stock has a market capitalization of $3.94 billion, a PE ratio of 19.44, a P/E/G ratio of 2.26 and a beta of 1.32. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $34.63.

Analyst Ratings Changes

OPCH has been the subject of a number of recent analyst reports. Truist Financial cut their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. JMP Securities boosted their price target on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. Barrington Research cut their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. Finally, Jefferies Financial Group cut Option Care Health from a “buy” rating to a “hold” rating and decreased their price target for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $30.83.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.